Clinical Trials Logo

Clinical Trial Summary

In the case of cardiovascular diseases such as coronary artery disease, cerebrovascular disease, and peripheral arterial disease, there are many studies that the use of antiplatelet agents is very helpful in improving the vascular patency rate, but there are not many studies on the use of antiplatelet agents in the dialysis approach. The basis for use is insufficient. There is a lack of research on whether maintaining a state in which platelet activation is suppressed is helpful in improving dialysis access patency. Therefore, we conducted this study to determine whether the degree of platelet activation affects the patency of vascular access.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05165797
Study type Observational
Source Korea University Anam Hospital
Contact
Status Recruiting
Phase
Start date January 1, 2021
Completion date July 1, 2022

See also
  Status Clinical Trial Phase
Completed NCT03355625 - Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients
Completed NCT03301129 - Role of Traditional Cigarettes, Electronic and IQOS Cigarettes on Oxidative Stress. N/A
Recruiting NCT04842760 - PLATELET Function Assay With Flow Imaging on ImageSTREAM Cytometer
Completed NCT01900639 - Aspirin AM or PM: Effect on Circadian Rhythm of Platelet Reactivity Phase 4
Recruiting NCT05646888 - Inflammation, Platelets and Sickle Cell Disease
Completed NCT04483245 - Platelet Activation by a Collagen Analogue in Hemorrhagic Situations
Recruiting NCT06033300 - Characterization and Quantification of Platelet/Leukocyte Aggregates in Patients With Suspected Heparin-induced Thrombocytopenia N/A